መነሻAMPH • NASDAQ
add
Amphastar Pharmaceuticals Inc
የቀዳሚ መዝጊያ
$44.55
የቀን ክልል
$44.95 - $45.65
የዓመት ክልል
$36.56 - $65.92
የገበያው አጠቃላይ ዋጋ
2.20 ቢ USD
አማካይ መጠን
374.44 ሺ
የዋጋ/ገቢ ምጥጥን
15.13
የትርፍ ክፍያ
-
ዋና ልውውጥ
NASDAQ
ፋይናንስ
የገቢ መግለጫ
ገቢ
የተጣራ ገቢ
| (USD) | ሴፕቴ 2024info | ከዓመት ዓመት ለውጥ |
|---|---|---|
ገቢ | 191.21 ሚ | 5.90% |
የሥራ ወጪ | 44.89 ሚ | 25.66% |
የተጣራ ገቢ | 40.43 ሚ | -17.86% |
የተጣራ የትርፍ ክልል | 21.14 | -22.45% |
ገቢ በሼር | 0.96 | -16.52% |
EBITDA | 70.45 ሚ | -17.41% |
ውጤታማ የግብር ተመን | 15.21% | — |
ቀሪ ሒሳብ ሉሆች
አጠቃላይ ንብረቶች
አጠቃላይ ተጠያቂነቶች
| (USD) | ሴፕቴ 2024info | ከዓመት ዓመት ለውጥ |
|---|---|---|
ጥሬ ገንዘብና የአጭር ጊዜ መዋዕለ ንዋይ | 250.49 ሚ | -16.47% |
አጠቃላይ ንብረቶች | 1.55 ቢ | 0.04% |
አጠቃላይ ተጠያቂነቶች | 817.50 ሚ | -13.90% |
አጠቃላይ እሴት | 727.68 ሚ | — |
የሼሮቹ ብዛት | 48.08 ሚ | — |
የገበያ ዋጋ እና የተገለጸ ዋጋ | 2.96 | — |
የእሴቶች ተመላሽ | 9.39% | — |
የካፒታል ተመላሽ | 10.60% | — |
የገንዘብ ፍሰት
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ
| (USD) | ሴፕቴ 2024info | ከዓመት ዓመት ለውጥ |
|---|---|---|
የተጣራ ገቢ | 40.43 ሚ | -17.86% |
ከክወናዎች የተገኘ ጥሬ ገንዘብ | 59.96 ሚ | -6.80% |
ገንዘብ ከኢንቨስትመንት | -34.59 ሚ | -11.02% |
ገንዘብ ከፋይናንስ | -22.82 ሚ | -126.34% |
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ | 2.50 ሚ | -97.91% |
ነፃ የገንዘብ ፍሰት | 25.06 ሚ | -49.93% |
ስለ
Amphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures, and sells inhalation and intranasal products.
One of its products is naloxone, an injectable generic drug that treats opioid overdose, and the company was criticized when it doubled the price of the drug from around $20 to $40 in 2015 during the opioid epidemic. In February 2017, the FDA rejected the company's application to market a device that delivers naloxone intranasally.
In March 2018, the company won a patent infringement lawsuit brought against it by Momenta Pharmaceuticals and Sandoz Inc in an ongoing antitrust case.
In April 2023, Amphastar Pharmaceuticals bought Baqsimi from Eli Lilly in a deal worth over $1bn. Wikipedia
የተመሰረተው
1996
ዋና መሥሪያ ቤት
ድህረገፅ
ሠራተኞች
1,761
